Want to join the conversation?
Simona Jankowski of Goldman Sachs asks whether sell-thru will exceed sell-in in 3Q16. $GPRO said the company is trying to manage both sell-in and sell-thru each quarter to be as close as it can be, even with the product launches. $GPRO manages its inventories as well as the inventories in the channel and will continue the same approach in future.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?